age research and all clinical, product development and commercialization activities. Under the Sanofi Agreement, the Group granted Sanofi an exclusive, worldwide, sublicensable license to research, d…
Reciprocal relationship from SNYNF graph: Reciprocal relationship from ADAG graph: age research and all clinical, product development and commercialization activities. Under the Sanofi Agreement, the…
age research and all clinical, product development and commercialization activities. Under the Sanofi Agreement, the Group granted Sanofi an exclusive, worldwide, sublicensable license to research, d…
Reciprocal relationship from SNYNF graph: Reciprocal relationship from ADAG graph: age research and all clinical, product development and commercialization activities. Under the Sanofi Agreement, the…
Adagene Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
ADAG-DEBT-7494
Warrants outstanding: 1000000
90%
xbrl warrant detail from xbrl 2025-12-31.
ADAG-DEBT-7495
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-12-31.
ADAG-DEBT
Debt stack $6.3M
90%
Market cache reports total debt of $6.3M.
Adagene Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Adagene Inc..
Adagene Inc. Ownership
Holder
Name
Confidence
Evidence
ADAG-OWNER-HSG-HOLDING-LTD
HSG Holding Ltd
90%
13F overlay lists HSG Holding Ltd as top holder; 26 tracked holders.